Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7053) 7053
Book Chapter (456) 456
Book / eBook (25) 25
Dissertation (25) 25
Conference Proceeding (20) 20
Government Document (17) 17
Publication (15) 15
Magazine Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (5030) 5030
life sciences & biomedicine (4891) 4891
humans (4309) 4309
oncology (3847) 3847
female (3489) 3489
metastatic breast cancer (3045) 3045
metastasis (2776) 2776
breast cancer (2654) 2654
middle aged (2400) 2400
aged (2107) 2107
adult (1888) 1888
breast neoplasms - pathology (1789) 1789
breast neoplasms - drug therapy (1707) 1707
cancer (1610) 1610
chemotherapy (1609) 1609
neoplasm metastasis (1483) 1483
tumors (1460) 1460
biological and medical sciences (1191) 1191
medical sciences (1185) 1185
treatment outcome (1095) 1095
male (1080) 1080
antineoplastic combined chemotherapy protocols - therapeutic use (1053) 1053
care and treatment (1013) 1013
medicine & public health (974) 974
prognosis (842) 842
metastases (840) 840
aged, 80 and over (814) 814
research (706) 706
antineoplastic agents (704) 704
metastatic (702) 702
analysis (635) 635
antineoplastic agents - therapeutic use (608) 608
pharmacology. drug treatments (602) 602
disease-free survival (600) 600
breast neoplasms - mortality (592) 592
patients (588) 588
retrospective studies (574) 574
gynecology. andrology. obstetrics (573) 573
mammary gland diseases (544) 544
cancer therapies (533) 533
animals (525) 525
pharmacology & pharmacy (507) 507
trastuzumab (484) 484
surgery (477) 477
antineoplastic combined chemotherapy protocols - adverse effects (471) 471
survival (468) 468
health aspects (464) 464
clinical trials (454) 454
survival analysis (439) 439
drug therapy (423) 423
breast neoplasms - metabolism (422) 422
development and progression (413) 413
neoplasm staging (407) 407
survival rate (396) 396
disease progression (387) 387
cancer research (383) 383
medical prognosis (370) 370
receptor, erbb-2 - metabolism (344) 344
deoxycytidine - analogs & derivatives (340) 340
capecitabine (333) 333
hematology, oncology and palliative medicine (329) 329
kaplan-meier estimate (325) 325
quality of life (325) 325
cancer patients (316) 316
bone neoplasms - secondary (312) 312
drug administration schedule (310) 310
pathology (306) 306
oncology, experimental (297) 297
fluorouracil - administration & dosage (290) 290
obstetrics & gynecology (288) 288
colorectal cancer (284) 284
follow-up studies (283) 283
docetaxel (282) 282
review (282) 282
patient outcomes (281) 281
deoxycytidine - administration & dosage (278) 278
medicine (278) 278
neoplasms. tumors. oncology. including cancer and carcinogens (277) 277
cell biology (274) 274
immunohistochemistry (274) 274
metastatic colorectal cancer (269) 269
cell line, tumor (265) 265
mice (265) 265
breast neoplasms - therapy (263) 263
bevacizumab (262) 262
breast neoplasms - genetics (261) 261
prostate cancer (259) 259
gene expression (257) 257
antineoplastic combined chemotherapy protocols - administration & dosage (256) 256
medical research (254) 254
skin and connective tissue diseases (251) 251
antineoplastic agents - administration & dosage (250) 250
metastatic disease (250) 250
paclitaxel (248) 248
paclitaxel - administration & dosage (246) 246
prospective studies (242) 242
diagnosis (240) 240
biomarkers (238) 238
risk factors (238) 238
genetic aspects (237) 237
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7326) 7326
Japanese (90) 90
German (73) 73
French (68) 68
Russian (66) 66
Spanish (37) 37
Polish (15) 15
Korean (13) 13
Chinese (12) 12
Czech (9) 9
Italian (8) 8
Portuguese (6) 6
Turkish (6) 6
Hungarian (3) 3
Norwegian (2) 2
Swedish (2) 2
Hebrew (1) 1
Indonesian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry
by Hartkopf, Andreas D and Huober, Jens and Volz, Bernhard and Nabieva, Naiba and Taran, Florin-Andrei and Schwitulla, Judith and Overkamp, Friedrich and Kolberg, Hans-Christian and Hadji, Peyman and Tesch, Hans and Häberle, Lothar and Ettl, Johannes and Lux, Michael P and Lüftner, Diana and Wallwiener, Markus and Müller, Volkmar and Beckmann, Matthias W and Belleville, Erik and Wimberger, Pauline and Hielscher, Carsten and Geberth, Matthias and Fersis, Nikos and Abenhardt, Wolfgang and Kurbacher, Christian and Wuerstlein, Rachel and Thomssen, Christoph and Untch, Michael and Fasching, Peter A and Janni, Wolfgang and Fehm, Tanja N and Wallwiener, Diethelm and Brucker, Sara Y and Schneeweiss, Andreas
Breast (Edinburgh), ISSN 0960-9776, 02/2018, Volume 37, pp. 42 - 51
Chemotherapy | Aromatase inhibitor | Advanced breast cancer | Therapy/treatment sequence | Metastatic | Tamoxifen | Everolimus | Antihormone therapy | Fulvestrant | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Care and treatment | Cancer patients | Breast cancer | Hormones | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients
by Stieber, Petra and Nagel, Dorothea and Blankenburg, Irene and Heinemann, Volker and Untch, Michael and Bauerfeind, Ingo and Di Gioia, Dorit
Clinica chimica acta, ISSN 0009-8981, 08/2015, Volume 448, pp. 228 - 231
Tumor marker | Recurrent disease | Metastatic disease | Increase | CA 15-3 | Breast cancer | Kinetics | CEA | Early detection | Life Sciences & Biomedicine | Medical Laboratory Technology | Science & Technology | Carcinoembryonic Antigen - blood | Humans | Middle Aged | Biomarkers, Tumor - blood | Young Adult | Breast Neoplasms - pathology | Mucin-1 - blood | Neoplasm Metastasis - diagnosis | Aged, 80 and over | Breast Neoplasms - blood | Adult | Female | Aged | Breast Neoplasms - diagnosis | Retrospective Studies | Care and treatment | Cancer patients | Metastasis | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Global analysis of advanced/metastatic breast cancer: Decade report (2005–2015)
by Cardoso, Fatima and Spence, Danielle and Mertz, Shirley and Corneliussen-James, Dian and Sabelko, Kimberly and Gralow, Julie and Cardoso, Maria-João and Peccatori, Fedro and Paonessa, Diego and Benares, Ann and Sakurai, Naomi and Beishon, Marc and Barker, Sarah-Jane and Mayer, Musa
Breast (Edinburgh), ISSN 0960-9776, 06/2018, Volume 39, pp. 131 - 138
Advanced breast cancer | Metastatic breast cancer | Global analysis | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Medical personnel | Caregivers | Medical research | Analysis | Medicine, Experimental | Medical care | Breast cancer | Patient satisfaction | Metastasis | Quality management | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer
by Lin, Aifu and Li, Chunlai and Xing, Zhen and Hu, Qingsong and Liang, Ke and Han, Leng and Wang, Cheng and Hawke, David H and Wang, Shouyu and Zhang, Yanyan and Wei, Yongkun and Ma, Guolin and Park, Peter K and Zhou, Jianwei and Zhou, Yan and Hu, Zhibin and Zhou, Yubin and Marks, Jeffery R and Liang, Han and Hung, Mien-Chie and Lin, Chunru and Yang, Liuqing
Nature cell biology, ISSN 1465-7392, 01/2016, Volume 18, Issue 2, pp. 213 - 224
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Heparin-binding EGF-like Growth Factor - pharmacology | Phosphorylation | Prognosis | Membrane Glycoproteins - metabolism | Protein-Tyrosine Kinases - metabolism | Humans | Multiprotein Complexes | Serine | Gene Expression Regulation, Neoplastic | Proline | Cytoplasm - metabolism | E1A-Associated p300 Protein - metabolism | Neoplasm Proteins - metabolism | Transfection | RNA Interference | Time Factors | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Triple Negative Breast Neoplasms - pathology | Female | Transcription, Genetic | Protein Stability | Protein-Serine-Threonine Kinases - metabolism | Tyrosine | ErbB Receptors - metabolism | Hydroxylation | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | RNA, Long Noncoding - genetics | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | Animals | Triple Negative Breast Neoplasms - genetics | Signal Transduction - drug effects | Mice, Nude | Cell Line, Tumor | Glycolysis | RNA, Long Noncoding - metabolism | Index Medicus | glycoprotein non-metastatic b (GPNMB) | Epidermal Growth Factor Receptor (EGFR) | Triple-negative Breast Cancer (TNBC) | Long Noncoding RNA | Signaling Transduction | Glycolysis Reprogramming | HIF1α
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2
by Beck, J Thaddeus and Beck, J Thaddeus and Hortobagyi, Gabriel N and Hortobagyi, Gabriel N and Campone, Mario and Campone, Mario and Lebrun, Fabienne and Lebrun, Fabienne and Deleu, Ines and Deleu, Ines and Rugo, Hope S and Rugo, Hope S and Pistilli, Barbara and Pistilli, Barbara and Masuda, Norikazu and Masuda, Norikazu and Hart, Lowell and Hart, Lowell and Melichar, Bohuslav and Melichar, Bohuslav and Dakhil, Shaker and Dakhil, Shaker and Geberth, Matthias and Geberth, Matthias and Nunzi, Martina and Nunzi, Martina and Heng, Daniel Y. C and Heng, Daniel Y. C and Brechenmacher, Thomas and Brechenmacher, Thomas and El-Hashimy, Mona and El-Hashimy, Mona and Douma, Shyanne and Douma, Shyanne and Ringeisen, Francois and Ringeisen, Francois and Piccart, Martine and Piccart, Martine
Breast cancer research and treatment, ISSN 0167-6806, 2/2014, Volume 143, Issue 3, pp. 459 - 467
mTOR inhibition | Metastatic disease | Medicine & Public Health | BOLERO-2 | First-line therapy | Oncology | Breast cancer | Everolimus | Life Sciences & Biomedicine | Science & Technology | Sirolimus - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Receptors, Estrogen - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Neoplasm Recurrence, Local - drug therapy | Clinical Trials as Topic | Receptors, Progesterone - genetics | Breast Neoplasms - drug therapy | Neoplasms, Hormone-Dependent - genetics | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Sirolimus - administration & dosage | Androstadienes - administration & dosage | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Neoplasms, Hormone-Dependent - pathology | Aged, 80 and over | Female | Aged | Neoplasms, Hormone-Dependent - drug therapy | Index Medicus | Clinical Trial
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
by Cardoso, F and Senkus, E and Costa, A and Papadopoulos, E and Aapro, M and André, F and Harbeck, N and Aguilar Lopez, B and Barrios, C H and Bergh, J and Biganzoli, L and Boers-Doets, C B and Cardoso, M J and Carey, L A and Cortés, J and Curigliano, G and Diéras, V and El Saghir, N S and Eniu, A and Fallowfield, L and Francis, P A and Gelmon, K and Johnston, S R D and Kaufman, B and Koppikar, S and Krop, I E and Mayer, M and Nakigudde, G and Offersen, B V and Ohno, S and Pagani, O and Paluch-Shimon, S and Penault-Llorca, F and Prat, A and Rugo, H S and Sledge, G W and Spence, D and Thomssen, C and Vorobiof, D A and Xu, B and Norton, L and Winer, E P
Annals of oncology, ISSN 0923-7534, 08/2018, Volume 29, Issue 8, pp. 1634 - 1657
ABC | Breast cancer | Metastatic | Advanced | ESO-ESMO | Guidelines | Life Sciences & Biomedicine | Oncology | Science & Technology | Chemoradiotherapy, Adjuvant - standards | Breast - surgery | Humans | Breast - diagnostic imaging | Mastectomy - methods | Breast Neoplasms - therapy | Evidence-Based Medicine - standards | Biomarkers, Tumor - metabolism | Female | Biopsy, Large-Core Needle | Societies, Medical - standards | Breast - pathology | Integrative Medicine - methods | Neoadjuvant Therapy - standards | Evidence-Based Medicine - methods | Medical Oncology - methods | Europe | Treatment Outcome | Clinical Trials as Topic | Consensus Development Conferences as Topic | Chemoradiotherapy, Adjuvant - methods | Breast Neoplasms - pathology | Integrative Medicine - standards | Neoadjuvant Therapy - methods | Mastectomy - standards | Medical Oncology - standards | Biomarkers, Tumor - genetics | Breast Neoplasms - diagnosis | Neoplasm Staging | Index Medicus | Life Sciences | Cancer | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Triple-negative breast cancer: Role of specific chemotherapy agents
by Isakoff, Steven J
The cancer journal (Sudbury, Mass.), ISSN 1528-9117, 01/2010, Volume 16, Issue 1, pp. 53 - 61
Chemotherapy | Carboplatin | Neoadjuvant | Metastatic | Basal-like breast cancer | Cisplatin | Triple-negative breast cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Receptors, Estrogen - metabolism | Prognosis | Breast Neoplasms - pathology | Humans | Receptor, ErbB-2 - metabolism | Female | Antineoplastic Agents - therapeutic use | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Index Medicus | basal-like breast cancer | neoadjuvant | metastatic | carboplatin | triple negative breast cancer | cisplatin | chemotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice
by Janni, Wolfgang and Schneeweiss, Andreas and Müller, Volkmar and Wöckel, Achim and Lux, Michael P and Hartkopf, Andreas D and Nabieva, Naiba and Taran, Florin-Andrei and Tesch, Hans and Overkamp, Friedrich and Lüftner, Diana and Belleville, Erik and Schütz, Florian and Fasching, Peter A and Fehm, Tanja N and Kolberg, Hans-Christian and Ettl, Johannes
Geburtshilfe und Frauenheilkunde, ISSN 0016-5751, 03/2019, Volume 79, Issue 3, pp. 268 - 280
GebFra Science | metastatic | PI3K | advanced | PD-L1 | breast cancer | atezolizumab | PARP | supportive therapy | alpelisib | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | fortgeschritten | Metastasen | Supportivtherapie | Mammakarzinom
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Improved survival in metastatic breast cancer 1985–2016
by Sundquist, Marie and Brudin, Lars and Tejler, Göran
Breast (Edinburgh), ISSN 0960-9776, 2016, Volume 31, pp. 46 - 50
Hematology, Oncology and Palliative Medicine | Breast cancer | Metastatic | Prognosis | Survival | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Survival Rate - trends | Trastuzumab - therapeutic use | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Agents - therapeutic use | Sweden - epidemiology | Breast Neoplasms - therapy | Disease-Free Survival | Neoplasm Metastasis | Breast Neoplasms - pathology | Adult | Breast Neoplasms - mortality | Female | Registries | Aged | Receptor, ErbB-2 - analysis | Metastasis | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights